Antony Gitau

2papers

2 Papers

1.2CVMar 20
Multi-Stage Fine-Tuning of Pathology Foundation Models with Head-Diverse Ensembling for White Blood Cell Classification

Antony Gitau, Martin Paulson, Bjørn-Jostein Singstad et al.

The classification of white blood cells (WBCs) from peripheral blood smears is critical for the diagnosis of leukemia. However, automated approaches still struggle due to challenges including class imbalance, domain shift, and morphological continuum confusion, where adjacent maturation stages exhibit subtle, overlapping features. We present a multi-stage fine-tuning methodology for 13-class WBC classification in the WBCBench 2026 Challenge (ISBI 2026). Our best-performing model is a fine-tuned DINOBloom-base, on which we train multiple classifier head families (linear, cosine, and multilayer perceptron (MLP)). The cosine head performed best on the mature granulocyte boundary (Band neutrophil (BNE) F1 = 0.470), the linear head on more immature granulocyte classes (Metamyelocyte (MMY) F1 = 0.585), and the MLP head on the most immature granulocyte (Promyelocyte (PMY) F1 = 0.733), revealing class-specific specialization. Based on this specialization, we construct a head-diverse ensemble, where the MLP head acts as the primary predictor, and its predictions within the four predefined confusion pairs are replaced only when two other head families agree. We further show that cases consistently misclassified by all models are substantially enriched for probable labeling errors or inherent morphological ambiguity.

1.3CVMay 12
What Does It Mean for a Medical AI System to Be Right?

Antony Gitau

This paper examines what it means for a medical AI system to be right by grounding the question in a specific clinical context: the automatic classification of plasma cells in digitized bone marrow smears for the diagnosis of multiple myeloma. Drawing on philosophy of science and research ethics, the paper argues that correctness in medical AI is not a singular property reducible to benchmark performance, but a multi-dimensional concept involving the availability of expertly labeled medical datasets, the explainability and interpretability of model outputs, the clinical meaningfulness of evaluation metrics, and the distribution of accountability in human-AI workflows. As such, the paper develops this argument through four interrelated themes: the instability of ground truth labels, the opacity of overconfident AI, the inadequacy of standard clinical metrics, and the risk of automation bias in time-pressured clinical settings.